Notebook

POSITIVE SIDE EFFECT Proposed legislation designed to ban genetic discrimination may boost participation in clinical trials, says Kathy L. Hudson, assistant director for policy coordination at the National Human Genome Research Institute. Vice President Al Gore issued guidelines for genetic discrimination legislation in a report entitled "Genetic Information and the Workplace" January 20 at the National Academy of Sciences. The legislation, if enacted, would bar employers from using genetic mak

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

POSITIVE SIDE EFFECT Proposed legislation designed to ban genetic discrimination may boost participation in clinical trials, says Kathy L. Hudson, assistant director for policy coordination at the National Human Genome Research Institute. Vice President Al Gore issued guidelines for genetic discrimination legislation in a report entitled "Genetic Information and the Workplace" January 20 at the National Academy of Sciences. The legislation, if enacted, would bar employers from using genetic makeup in hiring or promotion decisions. Candidates for clinical trials who decline to participate cite the misuse of genetic information as a major reason for their refusal, Hudson explains. The legislation would also allow more people to get tested for diseases without jeopardizing their employment-especially significant as genetic tests for more diseases become available. "There's now a handful of genes we can test for disease," Hudson reports. "That handful will grow to a boatful." Hudson says cases of employees losing their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies